Evidence map›Paper›PMID 31620136›Full record

ArticleFrontiers in immunology2019

Antibody Responses Against

Ada da Silva Matos, Rodrigo Nunes Rodrigues-da-Silva, Isabela Ferreira Soares, Barbara de Oliveira Baptista, Rodrigo Medeiros de Souza, Lana Bitencourt-Chaves, Paulo Renato Rivas Totino, Juan Camilo Sánchez-Arcila, Cláudio Tadeu Daniel-Ribeiro, César López-Camacho and 3 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 17 citations in OpenAlex.

  1. Immunogenicity ofFrontiers in cellular and infection microbiology · 2025
    Article
  2. Observational
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Frontiers in immunology · 2022
    Review
  10. Identification of Immunogenic Linear B-Cell Epitopes inPathogens (Basel, Switzerland) · 2021
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Ada da Silva MatosLaboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Rodrigo Nunes Rodrigues-da-SilvaLaboratory of Monoclonal Antibodies Technology, Institute of Immunobiology Technology, Fiocruz, Rio de Janeiro, Brazil.
Isabela Ferreira SoaresLaboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Barbara de Oliveira BaptistaLaboratory of Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Rodrigo Medeiros de SouzaCentre for Health Sciences and Sport, Federal University of Acre (UFAC), Cruzeiro Do Sul, Brazil.
Lana Bitencourt-ChavesLaboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Paulo Renato Rivas TotinoLaboratory of Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Juan Camilo Sánchez-ArcilaViral Immunology Laboratory, Oswaldo Cruz Institute, IOC, Oswaldo Cruz Foundation, Fiocruz, Rio de Janeiro, Brazil.
Cláudio Tadeu Daniel-RibeiroLaboratory of Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
César López-CamachoNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Arturo Reyes-SandovalNuffield Department of Medicine, The Jenner Institute, University of Oxford, Oxford, United Kingdom.
Lilian Rose Pratt-RiccioLaboratory of Malaria Research, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Josué da Costa Lima-JuniorLaboratory of Immunoparasitology, Oswaldo Cruz Institute, Fiocruz, Rio de Janeiro, Brazil.
Fundação Oswaldo Cruz · BRJenner Institute · GBUniversidade Federal do Acre · BR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Thrombospondin-related adhesive protein (TRAP) is essential for sporozoite motility and the invasion of mosquitoes' salivary gland and vertebrate's hepatocyte and is, thus, considered a promising pre-erythrocytic vaccine candidate. Despite the existence of a few reports on naturally acquired immune response against

Indexed as

AdultAmino Acid SequenceAntibodies, ProtozoanAntibody FormationBrazilCohort StudiesCross-Sectional StudiesEpitopes, B-LymphocyteFemaleHumansImmunoglobulin GMalaria VaccinesMalaria, VivaxMalePeptidesPlasmodium vivaxAntibodies, ProtozoanEpitopes, B-LymphocyteImmunoglobulin GMalaria VaccinesPeptidesProtozoan ProteinsThrombospondinsVaccines, Syntheticepitope mappinghumoral immune responsemalariaPlasmodium vivaxPvTRAP

Identifiers

PMID31620136
PMCPMC6763564
OpenAlexW2971515036

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.